Cat. No.: X23-10-ZQ364
JAK inhibitor CEP33779, Purity ≥98%
Synonym: CEP-33779; 1257704-57-6; CEP33779; N-(3-(4-Methylpiperazin-1-yl)phenyl)-8-(4-(methylsulfonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine; 1346168-57-7; N-[3-(4-Methylpiperazin-1-yl)phenyl]-8-(4-methylsulfonylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine; JAK inhibitor
- MDL: MFCD22683932
- CAS Number: 1257704-57-6
- Compound CID: 57336812
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
CEP33779, soluble in DMSO and insoluble in ethanol and water, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK2.
Molecular Formula
C24H26N6O2S
Solubility
DMSO: 33 mg/mL (71.34 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
CEP33779 can be used to study the inhibition of JAK2 and its implications in the treatment of inflammatory diseases and cancer.
Related Products
- JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
- JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
- JAK inhibitor Abrocitinib, Purity ≥98%
- JAK inhibitor AZ-3, Purity ≥98%
- JAK inhibitor AZ-960, Purity ≥98%
- JAK inhibitor AZD1480, Purity ≥98%
